Baidu
map

ADA 2016:心脏越健康糖尿病风险越低

2016-06-12 Seven L 译 MedSci原创

据美国糖尿病协会科学会议的一位发言人说,黑人成年人符合更多的美国心脏病协会(AHA)提出的理想心血管健康指标,他们的2型糖尿病风险会更低。“作为一名医生,我们可以衡量的危险因素有血压、体重指数、胆固醇、吸烟状况等,但是饮食和运动是我们不能评估的,”维克森林大学医学流行病学教授Alain Bertoni说,“有些指标是相互关联的。例如,一个健康的饮食和运动有助于控制体重和血压,同时可以改善血脂。”B

据美国糖尿病协会科学会议的一位发言人说,黑人成年人符合美国心脏病协会(AHA)提出的理想心血管健康指标的条件越多,他们的2型糖尿病风险会更低。

“作为一名医生,我们可以衡量的危险因素有血压、体重指数、胆固醇、吸烟状况等,但是饮食和运动是我们不能评估的,”维克森林大学医学流行病学教授Alain Bertoni说,“有些指标是相互关联的。例如,一个健康的饮食和运动有助于控制体重和血压,同时可以改善血脂。”

Bertoni和同事对2668名黑人成年人进行了一项研究,平均年龄55岁,女性占65.4%。研究者分析了AHA提出的6个心血管健康指标的基线数据:BMI、健康饮食、吸烟、总胆固醇、血压和体育锻炼。基于理想指标存在/不存在,对参与者的心血管健康评分(0-6),使用Cox回归分析评价参与者糖尿病发生风险。

总体而言,在随访的7.6年时间里共发生了492例糖尿病(24.6/1000人年)。在队列中,只有76%的参与者满足一个或两个理想的心血管健康指标,没有参与者的得分为6。

校正年龄、性别、教育和收入后,每增加一个心血管健康指标,糖尿病风险下降20%(HR = 0.8; 95% CI, 0.71-0.9);校正C反应蛋白后,联系仍存在(HR = 0.83; 95% CI, 0.74-0.93),校正HOMA-IR后,关联消失(HR = 0.89; 95% CI, 0.79-1)。

校正人口因素后,研究人员还发现,健康评分0-1的参与者与≥2的相比较,糖尿病风险更高(HR = 1.28; 95% CI, 1.06-1.56),校正HOMA-IR后,关联消失(HR = 1.13; 95% CI, 0.93-1.38)。

“AHA提出的理想的心血管健康适合非裔美国人的糖尿病预防,”Bertoni说,“对于每达到一个额外的心血管健康指标,糖尿病风险下降17%。实现心血管健康可以显著降低非裔美国人患糖尿病的风险。”

Bertoni说,希望在未来看到进一步的干预研究,无论是在个人还是卫生系统水平,以促进所有的美国人达到理想的心血管健康指标。

“很少有人达到这些目标,”Bertoni说,“也许最具挑战性的是饮食。有多个因素在影响饮食的选择,包括健康食品的成本、获得更健康的食品市场、快餐食品的相对方便等。”

原始出处:

Bertoni A. 87-OR. Presented at: American Diabetes Association Scientific Sessions; June 10-14, 2016; New Orleans.

AHA metrics for heart health may translate to diabetes prevention in black adults.Healio.June 11, 2016


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=132184, encodeId=c6db132184a8, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:46:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127463, encodeId=4f8912e4634c, content=谢谢分享,涨见识了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 13:39:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264569, encodeId=6052126456975, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Tue Jun 14 02:12:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89669, encodeId=1ba08966919, content=健康的心脏, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Jun 12 19:57:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89660, encodeId=ac7e89660ed, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89661, encodeId=f58c8966191, content=已经学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-09-21 1e10c84am36(暂无匿称)

    文章很好,非常有益

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=132184, encodeId=c6db132184a8, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:46:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127463, encodeId=4f8912e4634c, content=谢谢分享,涨见识了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 13:39:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264569, encodeId=6052126456975, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Tue Jun 14 02:12:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89669, encodeId=1ba08966919, content=健康的心脏, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Jun 12 19:57:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89660, encodeId=ac7e89660ed, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89661, encodeId=f58c8966191, content=已经学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-09-15 舒心和人

    谢谢分享,涨见识了,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=132184, encodeId=c6db132184a8, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:46:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127463, encodeId=4f8912e4634c, content=谢谢分享,涨见识了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 13:39:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264569, encodeId=6052126456975, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Tue Jun 14 02:12:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89669, encodeId=1ba08966919, content=健康的心脏, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Jun 12 19:57:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89660, encodeId=ac7e89660ed, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89661, encodeId=f58c8966191, content=已经学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-06-14 般若傻瓜
  4. [GetPortalCommentsPageByObjectIdResponse(id=132184, encodeId=c6db132184a8, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:46:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127463, encodeId=4f8912e4634c, content=谢谢分享,涨见识了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 13:39:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264569, encodeId=6052126456975, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Tue Jun 14 02:12:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89669, encodeId=1ba08966919, content=健康的心脏, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Jun 12 19:57:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89660, encodeId=ac7e89660ed, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89661, encodeId=f58c8966191, content=已经学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-06-12 老段

    健康的心脏

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=132184, encodeId=c6db132184a8, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:46:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127463, encodeId=4f8912e4634c, content=谢谢分享,涨见识了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 13:39:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264569, encodeId=6052126456975, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Tue Jun 14 02:12:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89669, encodeId=1ba08966919, content=健康的心脏, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Jun 12 19:57:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89660, encodeId=ac7e89660ed, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89661, encodeId=f58c8966191, content=已经学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-06-12 milkshark

    的确不错

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=132184, encodeId=c6db132184a8, content=文章很好,非常有益, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Wed Sep 21 08:46:00 CST 2016, time=2016-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=127463, encodeId=4f8912e4634c, content=谢谢分享,涨见识了,, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160907/IMG57D00CF1965701770.jpg, createdBy=565c1948251, createdName=舒心和人, createdTime=Thu Sep 15 13:39:00 CST 2016, time=2016-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264569, encodeId=6052126456975, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Tue Jun 14 02:12:00 CST 2016, time=2016-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89669, encodeId=1ba08966919, content=健康的心脏, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Sun Jun 12 19:57:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89660, encodeId=ac7e89660ed, content=的确不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89661, encodeId=f58c8966191, content=已经学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Sun Jun 12 19:54:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-06-12 milkshark

    已经学习

    0

相关资讯

拿糖尿病性水疱病不当并发症,后果很严重!

糖尿病性水疱病是糖尿病的特异性皮肤并发症,皮损特点酷似烧伤性水疱,其发病率为5%左右,多发生于患病时间较长、病情控制较差和全身营养不良(例如存在低蛋白血症)的糖尿病患者,尤其多见于合并有神经病变者。糖尿病性水疱病很容易被误诊,如果处理不当,还会引起感染及病情反复。 出现这样的临床表现,可不是烫伤哦! 糖尿病性水疱病起病多比较突然,无任何症状,往往在无意中察觉或被他人发现。 水疱形态酷似烧伤性水

甲亢遇上糖尿病,分不清楚就糟了!

甲状腺功能亢进症合并糖尿病的发生率为3.2%,其中弥漫性毒性甲状腺肿伴糖尿病的发生率为1.7%,结节性毒性甲状腺肿合并糖尿病高达5.6%。1型糖尿病合并甲亢的女性约占总发病率的7.5%,男性约占1.1%;2型糖尿病合并甲亢者中女性约占2.0%,男性占1.1%[1]。由此可见,甲亢合并糖尿病,这可是一件大事! 甲亢遇上糖尿病,这份“不二诊断”您会吗? 甲亢患者胰岛β细胞功能受损,甲状腺激素分泌过多,

JAMA Ophthalmol:糖尿病性黄斑水肿选择什么药更划算?

据糖尿病视网膜病变的临床研究网络协议T试验数据分析显示,治疗糖尿病性黄斑水肿时,阿柏西普和兰尼单抗没有贝伐单抗划算。这项研究的作者说:“这些结果突出了医生、患者和决策者在考虑安全性和有效性时所面临的成本效益的挑战。”该研究纳入了624名患者,随机分为Eylea (aflibercept, Regeneron)、Avastin (bevacizumab, Genentech)或Lucentis (r

一棵毒树结出的两颗恶果:糖尿病&多囊卵巢综合征

糖尿病&多囊卵巢综合征:你俩为啥“狼狈为奸”? 多囊卵巢综合征(PCOS)是女性最常见的内分泌紊乱疾病,在育龄妇女中的患病率为7%,以慢性无排卵和高雄激素血症为特征,常见的临床症状包括月经不调、不孕、多毛和肥胖等。其发病原因包括: ①下丘脑-垂体功能紊乱,黄体生成素分泌增多,卵泡刺激素正常或减少,加之高雄激素对下丘脑-垂体功能的干扰,影响卵泡发育; ②肾上腺功能异常影响下丘脑-垂体-卵

糖尿病神经病变,原来是这6大元凶作的祟!

糖尿病神经病变是糖尿病早期的并发症,较糖尿病肾病、糖尿病足出现早,但同样严重危害患者的身体健康。 神经病变可累及全身各部位神经,以外周神经病变和自主神经病变多见。外周神经病变以四肢疼痛、麻木、感觉丧失等为主要表现,增加足溃疡和截肢的风险;自主神经病变的发生往往是“悄无声息”的,多表现为心脏、胃、膀胱等器官的神经损伤,可引起体位性低血压、尿潴留、肌无力、勃起功能障碍等,有时亦无明显症状。 那么,引起

治疗糖尿病半路杀出个“盘头鲨”,怎么办?

众所周知,糖尿病极易并发感染。当糖尿病合并带状疱疹感染时,很容易发展成为带状疱疹后神经痛(PHN);70岁及以上的女性糖尿病患者在遭遇“盘头鲨”时,发生PHN的可能性更高。为了有效减轻患者的疼痛,我们需要做到“知己知彼”—— 知彼:糖尿病合并头面部带状疱疹的临床特点 糖尿病合并头面部带状疱疹,除存在头面部带状疱疹的典型表现(三叉神经分布区的点状红斑或斑片状疱疹)外,血糖控制较差者易继发细菌感染,加

Baidu
map
Baidu
map
Baidu
map